| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 03/18/2004 | WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | WO2004021969A2 Non-nucleoside reverse transcriptase inhibitors |
| 03/18/2004 | WO2004007459A3 Naphthol, quinoline and isoquinoline-derivatives as modulators of vanilloid vr1 receptor |
| 03/18/2004 | WO2003097576A3 Diamino-functional chalcones |
| 03/18/2004 | WO2003095421A8 Amino acid analogues |
| 03/18/2004 | WO2003071863A3 Brassica seeds |
| 03/18/2004 | WO2003018535A3 Novel aminobenzoephenones |
| 03/18/2004 | US20040054185 Antihistamines; cardiovascular disorders; cognition activators; Alzheimer's disease |
| 03/18/2004 | US20040054009 Useful for potentiating glutamate receptor function in a mammal and therefore useful for treating wide variety of conditions such as psychiatric and neurological disorders |
| 03/18/2004 | US20040054003 Pgd2 receptor antagonistic pharmaceutical compositions |
| 03/18/2004 | US20040053981 Such as 2-(5(6)-nitro-2-benzimidazoyl)-5-(4-nitrophenyl)furan; fluorescent quantitative analysis; for treatment/prevention of cancer |
| 03/18/2004 | US20040053953 Treatment of chemokine mediated diseases |
| 03/18/2004 | US20040053940 Interleukin 4 blockers; antiallergens |
| 03/18/2004 | US20040053935 Anticancer agents |
| 03/18/2004 | US20040053934 Anticancer agents |
| 03/18/2004 | US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto |
| 03/18/2004 | US20040053921 Compounds useful as reversible inhibitors of cysteine proteases |
| 03/18/2004 | US20040053908 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 03/18/2004 | US20040053907 Cell adhesion inhibitors |
| 03/18/2004 | US20040053775 Combinatorial approach to chiral reagents or catalysts having amine or amino alcohol ligands |
| 03/18/2004 | US20040053330 Amino polyols and amino sugars |
| 03/18/2004 | US20040052739 Sunscreen agents; radiation resistance |
| 03/18/2004 | DE19860844B4 Bis(trichlortrimellithsäureanhydrid)-Derivat und daraus hergestelltes Polyesterimid für die optische Nachrichtentechnik Bis (trichlortrimellithsäureanhydrid) derivative and produced therefrom Polyesterimide for optical communications technology |
| 03/18/2004 | DE10242351A1 Chirale Monophosphorverbindungen und deren Übergangsmetallkomplexe Chiral Mono phosphorus compounds and their transition metal complexes |
| 03/18/2004 | CA2501924A1 Non-nucleoside reverse transcriptase inhibitors |
| 03/18/2004 | CA2499380A1 Novel vinyl carboxylic acid derivatives and their therapeutical use |
| 03/18/2004 | CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | CA2497901A1 Furan or thiophene derivative and medicinal use thereof |
| 03/18/2004 | CA2495284A1 Diarylurea derivatives and their use as chloride channel blockers |
| 03/17/2004 | EP1398319A1 Chiral monophosphorus compounds and transition metal complexes thereof |
| 03/17/2004 | EP1398312A1 Beta-substituted-gamma-butyrolactones and a process for preparation thereof |
| 03/17/2004 | EP1398028A2 Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same |
| 03/17/2004 | EP1398024A2 Uses for thyroid hormone compounds |
| 03/17/2004 | EP1397341A1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 03/17/2004 | EP1397340A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/17/2004 | EP1397136A1 Heterocyclic beta-aminoacids and their use as anti-epileptogenic agents |
| 03/17/2004 | EP1397129A1 Heteroaryloxy 3-substituted propanamines s serotonin and norepinephrine reuptake inhibitors |
| 03/17/2004 | EP1246812B1 Method for the preparation of citalopram |
| 03/17/2004 | EP1171433B1 Preparation of norlabdane oxide |
| 03/17/2004 | EP1144365B1 Inhibitors of alpha-4 beta-1 mediated cell adhesion |
| 03/17/2004 | EP1140810B1 Benzenic sulphonamide derivatives and their uses |
| 03/17/2004 | EP1140802B1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines |
| 03/17/2004 | EP1137644B9 Benzofuran derivatives, their preparation and use |
| 03/17/2004 | EP1102760B1 Process for the oxidation of butadiene and butene with cobalt and molybdenum oxide based catalysts |
| 03/17/2004 | EP1100792B1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 03/17/2004 | EP0804429B1 Alkenyl substituted cyclic carboxyl acid anhydrides and their application in hydrophobic paper sizing |
| 03/17/2004 | CN1483043A Chitosan-containing multicomponent composition and process for preparing the same |
| 03/17/2004 | CN1483030A Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for the treatment of nervous system disorders |
| 03/17/2004 | CN1482123A Preparation method for cnidium fruit |
| 03/17/2004 | CN1482122A Intermediates for producing 2-thiosubstituted carbapenems |
| 03/17/2004 | CN1142107C Process for treating waste liquid of furaldehyde and recovering butyl acetate, ammonium sulfate, ammonium acetate, acetamide and acetonitrile |
| 03/16/2004 | US6706900 Prepared from a source of fructose in a one-pot, two-step reaction, in a single solvent system process, using a vanadium catalyst. |
| 03/16/2004 | US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/16/2004 | US6706754 Antiprotozoa agents, parasiticides |
| 03/16/2004 | US6706715 Reversible inhibitors of the blood clotting enzyme factor viia |
| 03/16/2004 | US6706712 Cyclic derivatives as modulators of chemokine receptor activity |
| 03/11/2004 | WO2004020426A1 Process for the production of an immunosuppressant |
| 03/11/2004 | WO2004020425A1 Improved process for the preparation of 5-substituted-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans |
| 03/11/2004 | WO2004020424A1 Process for preparing functionalized -butyrolactiones from mucohalic acid |
| 03/11/2004 | WO2004020413A1 Transition metal compounds, polymerization catalysts for conjugated dienes, process for production of conjugated diene polymers, polyisoprene and products of cyclization thereof, and process for production of the same |
| 03/11/2004 | WO2004020399A1 Malononitrile compound and use thereof as pesticides |
| 03/11/2004 | WO2004019874A2 Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma |
| 03/11/2004 | WO2003099759A8 Preparation and application of transhintotalphenolic acid |
| 03/11/2004 | WO2003091264A3 Non nucleoside reverse transcriptase inhibitors |
| 03/11/2004 | WO2003089615A3 Antiviral inhibitions of capsid proteins |
| 03/11/2004 | WO2003082861A3 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases |
| 03/11/2004 | WO2003065789A3 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | WO2003011849A8 Process for the production of beraprost and its salts |
| 03/11/2004 | WO2003002524A3 Urea derivatives with antiproteolytic activity |
| 03/11/2004 | US20040049072 RXR modulators with improved pharmacologic profile |
| 03/11/2004 | US20040049071 Contacting non-fluorous phase with fluorous phase at first phase interface; fluorous-tagged compound distributes between the phases; and contacting fluorous phase with second non-fluorous phase at a second phase interface. |
| 03/11/2004 | US20040049058 Process for preparing functionalized gamma-butyrolactiones from mucohalic acid |
| 03/11/2004 | US20040049057 Dihydro-furan-2-one derivatives, their intermediates and methods of manufacture |
| 03/11/2004 | US20040049040 Pohtochromic material |
| 03/11/2004 | US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease |
| 03/11/2004 | US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 03/11/2004 | US20040048922 Allomorph of isomer Z hydrochloride of alkylaminofurane derivative |
| 03/11/2004 | US20040048921 Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate |
| 03/11/2004 | US20040048913 Substituted biaryl amides as C5a receptor modulators |
| 03/11/2004 | US20040048907 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/11/2004 | US20040048895 Caspase-1 inhibitors and methods for their use |
| 03/11/2004 | US20040048875 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 03/11/2004 | US20040048858 Chalcone derivatives and their use to treat diseases |
| 03/11/2004 | US20040048785 By fibroblasts and/or keratinocytes; particularly hyaluronic acid, and/or proteoglycans |
| 03/11/2004 | US20040047824 Topical use containing at least one oxidation-sensitive hydrophilic active principle and at least one maleic anhydride copolymer, comprising one or more maleic anhydride comonomers and one or more comonomers selected from the group |
| 03/11/2004 | DE10240260A1 Formation of heteroatom-carbon bonds, giving products of interest for the pharmaceutical and agrochemical industries, comprises using an organolithium compound prepared by reacting an aliphatic or aromatic halide with lithium |
| 03/11/2004 | DE10238257A1 New compounds sorbicillactone A and derivatives, useful as antitumor, antiviral and antiinflammatory agents, obtained e.g. by culturing Penicillium fungi |
| 03/11/2004 | CA2495192A1 Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma |
| 03/11/2004 | CA2494748A1 Process for preparing functionalized .gamma.-butyrolactiones from mucohalic acid |
| 03/10/2004 | EP1395571A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 03/10/2004 | EP1395567A1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395561A1 Carbamate and oxamide compounds as inhibitors of cytokine production |
| 03/10/2004 | EP1395553A1 Pyrrolidine derivatives as factor xa inhibitors |
| 03/10/2004 | EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 03/10/2004 | EP1395549A1 Compounds and methods for preparing methanesulfonamides |
| 03/10/2004 | EP1395548A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
| 03/10/2004 | EP1395539A1 A method for isolating phenolic substances or juvabiones from wood comprising knotwood |
| 03/10/2004 | EP1395263A1 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| 03/10/2004 | EP1136477B1 Benzofuran derivatives, process for the preparation of the same and uses thereof |
| 03/10/2004 | EP1081132B1 Hydroxamic acid derivatives and medicinal utilization thereof |